SEC 13F Intelligence

S&Co Inc / BMY

S&Co Inc’s Bristol-Myers Squibb Co Position

Does S&Co Inc own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 279.3K shares worth $14M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$14M
Q4 2023
Shares
279.3K
% of Portfolio
+1.10%
Quarters Held
18
position exited

Position History BMY

Reported value by quarter
Q1 ’19: $19MQ1 ’19Q2 ’19: $18MQ3 ’19: $20MQ4 ’19: $26MQ4 ’19Q1 ’20: $23MQ4 ’20: $26MQ1 ’21: $26MQ1 ’21Q2 ’21: $28MQ3 ’21: $24MQ4 ’21: $25MQ4 ’21Q1 ’22: $30MQ2 ’22: $31MQ3 ’22: $29MQ3 ’22Q4 ’22: $29MQ1 ’23: $27MQ2 ’23: $25MQ2 ’23Q3 ’23: $19MQ4 ’23: $14Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023279.3K$14M+1.10%
Q3 2023323.6K$19M+1.54%
Q2 2023394.5K$25M+2.03%
Q1 2023394.6K$27M+2.32%
Q4 2022398.4K$29M+2.51%
Q3 2022402.7K$29M+2.58%
Q2 2022400.5K$31M+2.59%
Q1 2022404.8K$30M+2.08%
Q4 2021403.4K$25M+1.78%
Q3 2021399.5K$24M+1.84%
Q2 2021413.1K$28M+2.16%
Q1 2021414.7K$26M+2.20%
Q4 2020414.8K$26M+2.30%
Q1 2020410.2K$23M+3.05%
Q4 2019405.1K$26M+2.71%
Q3 2019397.8K$20M+2.23%
Q2 2019393.4K$18M+1.96%
Q1 2019400.9K$19M+2.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See S&Co Inc’s full portfolio or all institutional holders of BMY.